node1	node2	edge_score	
DB01579	ADRA1A	1.0	
DB01579	SLC6A2	1.0	
DB01579	ADRA1B	1.0	
ADRA1A		1.0
ADRA1B		1.0
SLC6A2	rs3785143	0.99
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	OR8D2	0.863824739585
SLC6A2	rs12708954	0.99
ADRA1B	complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	0.904977499353
SLC6A2	rs5569	0.99
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	KRT9	0.863824739585
SLC6A2		1.0
complex:lAo9+jzjVOaRJSWZQvoh0G1mUDc	ALB	0.863824739585
Methamphetamine abuse	ADRA1A	1.0	
Methamphetamine abuse	ALB	1.0	
Methamphetamine abuse	SLC6A2	1.0	
Hypotension	ADRA1A	1.0	
Hypotension	ADRA1B	1.0	
Hypotension	ALB	1.0	
Gastroparesis	ADRA1A	1.0	
Gastroparesis	ADRA1B	1.0	
Nephrosclerosis	ADRA1A	1.0	
Nephrosclerosis	ALB	1.0	
Essential hypertension	ADRA1A	1.0	
Essential hypertension	ADRA1B	1.0	
Essential hypertension	ALB	1.0	
Tourette Syndrome	ADRA1A	1.0	
Tourette Syndrome	SLC6A2	1.0	
Systemic arterial pressure	ADRA1A	1.0	
Systemic arterial pressure	ADRA1B	1.0	
Systemic arterial pressure	SLC6A2	1.0	
Polycystic Ovary Syndrome	ADRA1A	1.0	
Polycystic Ovary Syndrome	ADRA1B	1.0	
Polycystic Ovary Syndrome	ALB	1.0	
Attention deficit hyperactivity disorder	ADRA1A	1.0	
Attention deficit hyperactivity disorder	ADRA1B	1.0	
Attention deficit hyperactivity disorder	SLC6A2	1.0	
 Acrodysostosis 1, with or without hormone resistance, 101800 (3)	ADRA1A	1.0	
Slow acetylator due to N-acetyltransferase enzyme variant	SLC6A2	1.0	
Pseudohypoparathyroidism, type IB, 603233 (3)	ADRA1A	1.0	
Familial hypercholesterolemia	ADRA1A	1.0	
Familial hypercholesterolemia	ALB	1.0	
Dentinogenesis imperfecta	SLC6A2	1.0	
Chronic sciatica	ADRA1A	1.0	
Recurrent major depressive episodes	SLC6A2	1.0	
Asthma, Occupational	SLC6A2	1.0	
Malignant neoplasm of adrenal cortex	ALB	1.0	
Behavior Disorders	SLC6A2	1.0	
Esophageal varix	ALB	1.0	
Disorders of parathyroid gland	ADRA1A	1.0	
Urolithiasis	ALB	1.0	
genetic hypertension	ADRA1A	1.0	
Echinococcosis	ALB	1.0	
Hereditary Sensory Autonomic Neuropathy, Type 1	ADRA1A	1.0	
Epidermolysis bullosa simplex, Cockayne-Touraine type	KRT9	1.0	
Palmar hyperkeratosis	KRT9	1.0	
Bladder neck obstruction	ADRA1A	1.0	
Proliferative retinopathy	ALB	1.0	
Orofacial cleft	SLC6A2	1.0	
Verrucae	KRT9	1.0	
Taste bitter	ADRA1A	1.0	
Isolated somatotropin deficiency	ALB	1.0	
Substance Use Disorders	ALB	1.0	
Dentatorubral pallidoluysian atrophy	ALB	1.0	
Angiokeratoma	ALB	1.0	
Isolated growth hormone deficiency type 1B	ALB	1.0	
Congenital long QT syndrome	ADRA1A	1.0	
Plantar hyperkeratosis	KRT9	1.0	
Kidney Failure, Chronic	ADRA1A	1.0	
Kidney Failure, Chronic	ADRA1B	1.0	
Kidney Failure, Chronic	ALB	1.0	
Systemic aspergillosis	SLC6A2	1.0	
Pericardial effusion	ALB	1.0	
Pulmonary Cystic Fibrosis	ADRA1A	1.0	
Mumps	ALB	1.0	
Rhinitis, Allergic, Perennial	ALB	1.0	
Endemic Cretinism	ALB	1.0	
Hemangioblastoma	ALB	1.0	
Chronic schizophrenia	ADRA1A	1.0	
Hypoparathyroidism - autosomal dominant	ADRA1A	1.0	
Acute postoperative pain	ADRA1A	1.0	
Acute disease of cardiovascular system	ADRA1A	1.0	
Mesangiocapillary glomerulonephritis, type II	ALB	1.0	
Personality disorder	SLC6A2	1.0	
Peripheral motor neuropathy	ALB	1.0	
Paroxysmal atrial fibrillation	ADRA1A	1.0	
End Stage Liver Disease	ALB	1.0	
Cholestasis of pregnancy	ADRA1A	1.0	
Abnormal albumin level	ALB	1.0	
Neurotoxicity Syndromes	ADRA1B	1.0	
Bronchogenic Carcinoma	ALB	1.0	
Low back pain	ADRA1A	1.0	
Nephrogenic diabetes insipidus, autosomal	ADRA1A	1.0	
Coronary artery aneurysm	ALB	1.0	
Hyperlipoproteinemia	ALB	1.0	
Hyperlipoproteinemia Type IIa	ALB	1.0	
Disseminated intravascular coagulation	SLC6A2	1.0	
Tubulointerstitial nephritis	ALB	1.0	
Single tumor	ALB	1.0	
Nephrotic Syndrome, Minimal Change	ALB	1.0	
Skin Diseases, Genetic	KRT9	1.0	
Weight Loss Adverse Event	SLC6A2	1.0	
Varicella zoster	ALB	1.0	
Drusen	ALB	1.0	
Fibromyalgia	ADRA1A	1.0	
Increased antibody level in blood	KRT9	1.0	
Insulin resistance syndrome	ALB	1.0	
Dyskinesia, Drug-Induced	ADRA1A	1.0	
Abnormal autonomic nervous system physiology	SLC6A2	1.0	
Nephrosis	ALB	1.0	
Spondylitis, Ankylosing	ADRA1B	1.0	
Congestive heart failure	ADRA1A	1.0	
Congestive heart failure	ALB	1.0	
Congestive heart failure	SLC6A2	1.0	
Guillain-Barre syndrome, familial	ALB	1.0	
Primary hyperparathyroidism	ALB	1.0	
Drug Resistant Epilepsy	ALB	1.0	
Heart Failure	ADRA1A	1.0	
Heart Failure	ALB	1.0	
Heart Failure	SLC6A2	1.0	
Low Tension Glaucoma	ADRA1A	1.0	
Cleft palate with cleft lip	SLC6A2	1.0	
Memory Disorders	ADRA1A	1.0	
Respiratory Tract Diseases	ALB	1.0	
Sicca Syndrome	ALB	1.0	
Hypoalbuminemia	ALB	1.0	
Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	ALB	1.0	
Abnormality of the plantar skin of foot	KRT9	1.0	
Inflammatory pain	ADRA1A	1.0	
Cancer Cell Growth	ADRA1A	1.0	
Cancer Cell Growth	SLC6A2	1.0	
Mood Disorders	ADRA1B	1.0	
Mood Disorders	SLC6A2	1.0	
Congenital hypothyroidism	ALB	1.0	
Adverse drug events and drug allergies	ALB	1.0	
Hypertension	ADRA1A	1.0	
Hypertension	ADRA1B	1.0	
Hypertension	ALB	1.0	
Hypertension	SLC6A2	1.0	
Hypogonadism with anosmia	ADRA1A	1.0	
Periodontitis	ALB	1.0	
Periodontitis	SLC6A2	1.0	
Carcinoma breast stage IV	ALB	1.0	
Carcinoma breast stage IV	SLC6A2	1.0	
Hemolytic uremic syndrome	ALB	1.0	
Heroin Dependence	SLC6A2	1.0	
Colorectal polyposis	SLC6A2	1.0	
